On July 30, 2025, InspireMD, Inc. entered into a securities purchase agreement to sell 6,791,380 shares of common stock and pre-funded warrants for approximately $40.1 million. Additionally, on July 31, 2025, they appointed Ray Cohen to the board and announced a full exercise of warrants yielding around $17.9 million in proceeds.